Eastwood Bio-Medical Canada (TSXV:EBM) ROCE % : 0.00% (As of Oct. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Eastwood Bio-Medical Canada ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Eastwood Bio-Medical Canada's annualized ROCE % for the quarter that ended in Oct. 2024 was 0.00%.

Eastwood Bio-Medical Canada ROCE % Historical Data

The historical data trend for Eastwood Bio-Medical Canada's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eastwood Bio-Medical Canada ROCE % Chart

Eastwood Bio-Medical Canada Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

ROCE %

Get a 7-Day Free Trial

-95.04

-325.75

Eastwood Bio-Medical Canada Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Eastwood Bio-Medical Canada ROCE % Calculation

Eastwood Bio-Medical Canada's annualized ROCE % for the fiscal year that ended in Oct. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Oct. 2024 )		(A: Oct. 2023 )		(A: Oct. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Oct. 2024 )		(A: Oct. 2023 )		(A: Oct. 2024 )
	=	-0.45	/	( ( (0.489 - 1.33)	+	(0.274 - 1.571) )	/ 2 )
	=	-0.45	/	( (-0.841	+	-1.297)	/ 2 )
	=	-0.45	/	-1.069
	=	42.10 %

Eastwood Bio-Medical Canada's ROCE % of for the quarter that ended in Oct. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Oct. 2024 )		(Q: Jul. 2024 )		(Q: Oct. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Oct. 2024 )		(Q: Jul. 2024 )		(Q: Oct. 2024 )
	=	-0.6	/	( ( (0.331 - 1.472)	+	(0.274 - 1.571) )	/ 2 )
	=	-0.6	/	( ( -1.141	+	-1.297 )	/ 2 )
	=	-0.6	/	-1.219
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Oct. 2024) EBIT data.

Eastwood Bio-Medical Canada (TSXV:EBM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Eastwood Bio-Medical Canada ROCE % Related Terms

Thank you for viewing the detailed overview of Eastwood Bio-Medical Canada's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Eastwood Bio-Medical Canada Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » Eastwood Bio-Medical Canada Inc (TSXV:EBM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4871 Shell Road, Suite 1130, Richmond, BC, CAN, V6X 3Z6

Website

https://www.eleotin.ca

Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in U.S., Canada and Asia. The company generates maximum revenue from Asia.

Executives

Yunji Kim	Senior Officer
Youngsoo Kim	Director or Senior Officer of 10% Security Holder

Eastwood Bio-Medical Canada Headlines

No Headlines